{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:34:39Z","timestamp":1793705679150,"version":"4.5.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2015\/03756-4"],"award-info":[{"award-number":["2015\/03756-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2018\/16162-3"],"award-info":[{"award-number":["2018\/16162-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["303422\/2015-7"],"award-info":[{"award-number":["303422\/2015-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["305068\/2014-8"],"award-info":[{"award-number":["305068\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["305556\/2017-7"],"award-info":[{"award-number":["305556\/2017-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["306879\/2018-2"],"award-info":[{"award-number":["306879\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jvacx.2021.100131","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T21:18:51Z","timestamp":1639084731000},"page":"100131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases"],"prefix":"10.1016","volume":"10","author":[{"given":"N\u00e1dia","family":"Emi Aikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Andrade Balbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Ferreira","family":"Borba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Coracini Tonacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Maluf Elias Sallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Maria Arruda Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia","family":"Tomie Kozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Borges Vendramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fontoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"de Souza Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleska","family":"Dias Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marli Christovam Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Antonangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis","family":"Artur Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jvacx.2021.100131_b0005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrrheum.2013.95","article-title":"Vaccinations in juvenile chronic inflammatory diseases: an update","volume":"9","author":"Silva","year":"2013","journal-title":"Nat Rev Rheumato"},{"key":"10.1016\/j.jvacx.2021.100131_b0010","doi-asserted-by":"crossref","unstructured":"Silva CA, Terreri MT, Aikawa NE, Carvalho JF, Pileggi GC, et al. Vaccination practice in children with rheumatic disease. Rev Bras Reumatol 2010;50(4):351-61.","DOI":"10.1590\/S0482-50042010000400002"},{"issue":"1","key":"10.1016\/j.jvacx.2021.100131_b0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3899\/jrheum.110721","article-title":"Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease","volume":"39","author":"Aikawa","year":"2012","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jvacx.2021.100131_b0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.vaccine.2014.12.030","article-title":"Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy","volume":"33","author":"Aikawa","year":"2015","journal-title":"Vaccine"},{"key":"#cr-split#-10.1016\/j.jvacx.2021.100131_b0025.1","unstructured":"Pan American Health Organization (PAHO) and the World Health Organization (WHO). Washington: Pan American Health Organization [update in 2018 February 20"},{"key":"#cr-split#-10.1016\/j.jvacx.2021.100131_b0025.2","unstructured":"accessed in 2018 February]. Brazil launches world's largest campaign with fractional-dose yellow fever vaccine.Available:https:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=14065&Itemid=135&lang=pt."},{"issue":"10","key":"10.1016\/j.jvacx.2021.100131_b0030","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jvacx.2021.100131_b0035","unstructured":"Petty RR, Southwood T, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision Edmonton 2001. J Rheumatol 2004;31(2):390-2."},{"issue":"9","key":"10.1016\/j.jvacx.2021.100131_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jvacx.2021.100131_b0045","doi-asserted-by":"crossref","unstructured":"Zulian F, Woo P, Athreya BH, Laxer RM, Medsger Jr TA, Lehman TJA, et al. The PRES\/ACR\/EULAR provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 2007;15;57(2):203-12.","DOI":"10.1002\/art.22551"},{"issue":"7","key":"10.1016\/j.jvacx.2021.100131_b0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2021.100131_b0055","doi-asserted-by":"crossref","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010;69(5):798-806.","DOI":"10.1136\/ard.2009.116657"},{"issue":"7","key":"10.1016\/j.jvacx.2021.100131_b0060","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/annrheumdis-2013-204186","article-title":"Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score","volume":"73","author":"Consolaro","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jvacx.2021.100131_b0065","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29(2):288-91."},{"key":"10.1016\/j.jvacx.2021.100131_b0070","doi-asserted-by":"crossref","unstructured":"Lovell DJ1, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999; 42(10):2213-9.","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8"},{"issue":"6","key":"10.1016\/j.jvacx.2021.100131_b0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biologicals.2012.09.005","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biologicals."},{"key":"10.1016\/j.jvacx.2021.100131_b0080","doi-asserted-by":"crossref","unstructured":"Mota LM, Oliveira AC, Lima RA, Santos-Neto LL, Tauil PL. Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases. Rev Soc Bras Med Trop 2009;42(1):23-7.","DOI":"10.1590\/S0037-86822009000100006"},{"issue":"2","key":"10.1016\/j.jvacx.2021.100131_b0085","first-page":"582","article-title":"Seroconversion in Patients With Rheumatic Diseases Treated With Immunomodulators or Immunosuppressants","volume":"67","author":"Oliveira","year":"2015","journal-title":"Who Were Inadvertently Revaccinated Against Yellow Fever Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jvacx.2021.100131_b0090","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax082","article-title":"Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel Clinics","volume":"25","author":"Huber","year":"2018","journal-title":"J Travel Med"},{"issue":"23","key":"10.1016\/j.jvacx.2021.100131_b0095","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/jama.2013.6768","article-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial","volume":"309","author":"Heijstek","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jvacx.2021.100131_b0100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","article-title":"Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids","volume":"62","author":"Pileggi","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.jvacx.2021.100131_b0105","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2020.01.037","article-title":"PReS working party of Vaccination Study Group. Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection","volume":"38","author":"Uziel","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2021.100131_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-018-0235-z","article-title":"The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey","volume":"16","author":"Jeyaratnam","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.jvacx.2021.100131_b0115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1710430","article-title":"Immunogenicity of fractional-dose vaccine during a yellow fever outbreak - final report","volume":"381","author":"Casey","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jvacx.2021.100131_b0120","doi-asserted-by":"crossref","unstructured":"Roukens AHE, van Halem K, de Visser AW, Visser LG. Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial. Ann Intern Med. 2018;169(11):761-5.","DOI":"10.7326\/M18-1529"},{"key":"10.1016\/j.jvacx.2021.100131_b0125","unstructured":"World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper June 2013. Wkly Epidemiol Rec 2013;27(88):269e84."},{"key":"10.1016\/j.jvacx.2021.100131_b0130","doi-asserted-by":"crossref","unstructured":"Muturi-Kioi V, Lewis D, Launay O, Leroux-Roels G, Anemona A, Loulergue P, et al. Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review. PLoS One. 2016;11(8):e0157385.","DOI":"10.1371\/journal.pone.0157385"},{"issue":"4","key":"10.1016\/j.jvacx.2021.100131_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/v9040077","article-title":"T Cell-mediated immunity towards yellow fever virus and useful animal models","volume":"9","author":"Watson","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.jvacx.2021.100131_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2016.01.001","article-title":"Type I interferons in viral control and immune regulation","volume":"16","author":"Teijaro","year":"2016","journal-title":"Curr Opin Virol"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136221000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136221000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:06:03Z","timestamp":1762913163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136221000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":29,"alternative-id":["S2590136221000486"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2021.100131","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2021.100131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100131"}}